SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-352731
Filing Date
2012-08-13
Accepted
2012-08-13 17:16:24
Documents
6
Period of Report
2012-08-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d397184d8k.htm 8-K 40119
2 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION d397184dex31.htm EX-3.1 6217
3 FIFTH AMENDED AND RESTATED BYLAWS d397184dex32.htm EX-3.2 63929
4 CERTIFICATE OF FORMATION, DATED AS OF AUGUST 8, 2012 d397184dex33.htm EX-3.3 3705
5 LIMITED LIABILITY COMPANY AGREEMENT DATED AS OF AUGUST 8, 2012 d397184dex34.htm EX-3.4 28739
6 SUPPLEMENTAL INDENTURE, DATED AUGUST 8, 2012 d397184dex42.htm EX-4.2 18925
  Complete submission text file 0001193125-12-352731.txt   163498
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Filer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19700 | Film No.: 121028538
SIC: 2834 Pharmaceutical Preparations